CSIMarket
 
Airsculpt Technologies Inc   (NASDAQ: AIRS)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $2.5200 $-0.08 -3.077%
Day's High: $2.5899999141693115 Week Perf: -5.62 %
Day's Low: $ 2.49 30 Day Perf: -47.61 %
Volume (M): 679,202 52 Wk High: $ 12.00
Volume (M$): $ 0 52 Wk Avg: $4.34
Open: $2.54 52 Wk Low: $1.51



 Market Capitalization (Millions $) 178
 Shares Outstanding (Millions) 71
 Employees 363
 Revenues (TTM) (Millions $) 151
 Net Income (TTM) (Millions $) -12
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) 0

Business Description


Airsculpt Technologies Inc is a medical technology company that specializes in non-invasive and minimally invasive fat removal procedures.
The company was founded in 2015 by Dr.
Aaron Rollins, who is a renowned plastic surgeon and expert in body contouring techniques.
The company's signature procedure is called AirSculpt, which uses patented technology and techniques to remove fat cells from the body.
AirSculpt is a minimally invasive procedure that uses a small cannula to remove fat cells, without the need for general anesthesia or major incisions.
The process involves injecting a specially formulated solution into the treatment area, which then emulsifies the fat cells and makes them easier to remove.
The cannula is then inserted into the treatment area, and the fat cells are suctioned out of the body.
Airsculpt Technologies Inc has developed a variety of different AirSculpt procedures, each of which is specifically designed to address different areas of the body.
These include treatments for the arms, thighs, buttocks, abdomen, and other areas.
The company's technology is based on a series of patents that Dr.
Rollins has developed, which cover everything from the design of the cannula to the formulation of the solution that is used.
Airsculpt Technologies Inc is also committed to using sustainable materials and reducing waste in its procedures.
The company uses reusable cannulas and recyclable packaging materials, as well as minimizing the use of single-use plastics.
In addition to its focus on fat removal procedures, Airsculpt Technologies Inc is also involved in research and development of other medical technologies related to body and facial contouring.
Overall, Airsculpt Technologies Inc is a cutting-edge medical technology company that is focused on providing innovative, minimally invasive solutions to body contouring and fat removal.
Its AirSculpt procedures are gaining popularity and becoming an increasingly popular option for people looking to achieve their ideal body shape.


   Company Address: 1111 Lincoln Road Miami Beach 33139 FL
   Company Phone Number: 709-9690   Stock Exchange / Ticker: NASDAQ AIRS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ROL   -3.19%    
• View Complete Report
   



Management Announcement

AirSculpt Technologies Faces Uncertain Future Amid Leadership Changes and Declining Employee Productivity,

Published Mon, Jan 13 2025 11:45 AM UTC

By Miami Beach, Fla. — AirSculpt Technologies, Inc. (NASDAQ: AIRS) is implementing strategic changes and updating projections for fiscal year 2024, yet the company s recent performance metrics signal a tougher road ahead. With the company gearing up to present at the ICR Conference 2025, questions linger about its capacity to regain traction in an increasingly competitive ...

Management Changes

AirSculpt Technologies Elevates Leadership with Yogi Jashnani as New CEO, Poised for Strategic Growth

Published Tue, Dec 17 2024 11:45 AM UTC

In a significant move that underscores its commitment to innovation and excellence in the field of body contouring, AirSculpt Technologies, Inc. (NASDAQ:AIRS) has announced the appointment of Yogi Jashnani as the new Chief Executive Officer (CEO) and a member of the Board of Directors. This strategic leadership transition is set to take effect on January 7, 2025, with Yogi s...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.18
Price to Sales (Expected) -
Price to Book 1.7
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.54
Working Capital Ratio 0.79
Leverage Ratio (MRQ) 0.84
Total Debt to Equity 0.52
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.18 $
Revenues (TTM) 2.13 $
Cash Flow (TTM) 0.12 $
Cash 0.27 $
Book Value 1.48 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 415,218
Net Income per Employee (TTM) -32,336
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.79

Profitability Ratios Current
Gross Margin (MRQ) 61.38 %
Operating Margin (MRQ) -0.07 %
Net Margin (MRQ) -2.59 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Airsculpt Technologies Inc's Segments
Reportable    191.82 % of total Revenue

  Airsculpt Technologies Inc Outlook

On January 13 2025 the Airsculpt Technologies Inc provided following guidance

nnAirSculpt Technologies Inc. Revises Fiscal Year 2024 Financial Projections Ahead of ICR Conference 2025nn

nMIAMI BEACH, Fla., January 13, 2025n — AirSculpt Technologies, Inc. (NASDAQ: AIRS), a prominent provider of high-end body contouring procedures, has announced today an updated outlook for its fiscal year 2024. This revision comes as the Company prepares to participate in the upcoming ICR Conference 2025, where it will share insights and updates with stakeholders.

While AirSculpt has outlined its commitment to enhancing its financial strategy and growth trajectory, precise figures and specific details regarding the updated fiscal year 2024 guidance have not been disclosed in this an...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.